EUVIMEDObjevte EUVIMED
Qualitative StudieOpen access

Developing an AI-Assisted Tool That Identifies Patients With Multimorbidity and Complex Polypharmacy to Improve the Process of Medication Reviews: Qualitative Interview and Focus Group Study

Entwicklung eines KI-gestützten Tools zur Identifikation von Patient:innen mit Multimorbidität und komplexer Polypharmazie zur Verbesserung des Medikationsreviews: qualitative Interview- und Fokusgruppenstudie

Aseel S Abuzour iD, Samantha A Wilson iD, Alan A Woodall iD, Frances S Mair iD, Asra Aslam iD, Andrew Clegg iD, Eduard Shantsila iD, Mark Gabbay iD, Michael Abaho iD, Danushka Bollegala iD, Harriet Cant iD, Alan Griffiths iD and 13 more

Journal of Medical Internet Research · 2026-01-08 · 28 · e74304

DOI: 10.2196/74304 ↗

Auf einen Blick

Die Studie untersuchte die Perspektiven von HCPs zur Einbindung KI-gestützter Tools in strukturierte Medikationsreviews. Genannt wurden potenzielle Vorteile für Identifikation und Priorisierung sowie Barrieren bei Integration und Akzeptanz.

Fragestellung

Welche Nutzeranforderungen sehen HCPs für KI-gestützte Tools, die den Prozess strukturierter Medikationsreviews bei Multimorbidität, komplexer Polypharmazie und Frailty verbessern sollen?

Methode

Qualitative Studie mit Fokusgruppen und halbstrukturierten Interviews mit HCPs und Patient:innen im Vereinigten Königreich; thematische Analyse mit induktivem und deduktivem Ansatz.

Ergebnisse

Es ergaben sich 4 Hauptthemen: KI-Potenzial, bessere Visualisierung elektronischer Patientendaten, Funktionalität des Tools für SMRs sowie Förderfaktoren und Barrieren der Implementierung. Genannt wurden u. a. Identifikation von Risikopatient:innen, Erkennung von Verordnungslücken und Interaktionen.

Einschränkungen

Einige Teilnehmende waren skeptisch gegenüber der Vorhersagegenauigkeit von KI-Modellen; zudem wurden Sorgen über digitale Ausgrenzung genannt.

Schlussfolgerung der Autor:innen

Die Ergebnisse zeigen Potenzial für KI-gestützte Tools zur Straffung und Optimierung von SMRs. Der Erfolg hängt laut Autor:innen von Workflow-Integration, Nutzerakzeptanz und Evidenz zur Wirksamkeit ab.

Kernaussagen

  • 4 Hauptthemen zur Nutzung von KI im SMR-Prozess
  • KI soll Patient:innen identifizieren und Risiken priorisieren
  • Wichtig sind intuitive Darstellung und Einbettung in bestehende Systeme

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Qualitative Studie in Journal of Medical Internet Research, published online on 2026-01-08. Written by Aseel S Abuzour and 24 co-authors. Institution: Academic Unit for Ageing & Stroke Research, University of Leeds, Leeds, United Kingdom. Major MEDLINE topics: Artificial Intelligence, Polypharmacy, Multimorbidity. Cited 8 times so far (Crossref); 35 references. The full text is freely available in PubMed Central.

Auf einen BlickAbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Structured medication reviews (SMRs) are an essential component of medication optimization, especially for patients with multimorbidity and polypharmacy. However, the process remains challenging due to the complexities of patient data, time constraints, and the need for coordination among health care professionals (HCPs). This study explores HCPs’ perspectives on the integration of artificial intelligence (AI)–assisted tools to enhance the SMR process, with a focus on the potential benefits of and barriers to adoption.

Objective

This study aims to identify the key user requirements for AI-assisted tools to improve the efficiency and effectiveness of SMRs, specifically for patients with multimorbidity, complex polypharmacy, and frailty.

Methods

A qualitative study was conducted involving focus groups and semistructured interviews with HCPs and patients in the United Kingdom. Participants included physicians, pharmacists, clinical pharmacologists, psychiatrists from primary and secondary care, a policy maker, and patients with multimorbidity. Data were analyzed using a hybrid inductive and deductive thematic analysis approach to identify themes related to AI-assisted tool functionality, workflow integration, user-interface visualization, and usability in the SMR process.

Results

Four major themes emerged from the analysis: innovative AI potential, optimizing electronic patient record visualization, functionality of the AI tool for SMRs, and facilitators of and barriers to AI tool implementation. HCPs identified the potential of AI to support patient identification and prioritizing those at risk of medication-related harm. AI-assisted tools were viewed as essential in detecting prescribing gaps, drug interactions, and patient risk trajectories over time. Participants emphasized the importance of presenting patient data in an intuitive format, with a patient interface for shared decision-making. Suggestions included color-coding blood results, highlighting critical medication reviews, and providing timelines of patient medical histories. HCPs stressed the need for AI tools to integrate seamlessly with existing electronic patient record systems and provide actionable insights without overwhelming users with excessive notifications or “pop-up” alerts. Factors influencing the uptake of AI-assisted tools included the need for user-friendly design, evidence of tool effectiveness (though some were skeptical about the predictive accuracy of AI models), and addressing concerns around digital exclusion.

Conclusions

The findings highlight the potential for AI-assisted tools to streamline and optimize the SMR process, particularly for patients with multimorbidity and complex polypharmacy. However, successful implementation depends on addressing concerns related to workflow integration, user acceptance, and evidence of effectiveness. User-centered design is crucial to ensure that AI-assisted tools support HCPs in delivering high-quality, patient-centered care while minimizing cognitive overload and alert fatigue.

Subjects

MeSH terms (MEDLINE)

Artificial IntelligencePolypharmacyMultimorbidityHumansFocus GroupsFemaleQualitative ResearchInterviews as TopicMaleIntelligent SystemsDigital HealthUnited KingdomMiddle Aged

Author keywords

AIartificial intelligencehealth technologymedicine optimizationrisk stratificationstructured medication reviews

Authors and institutions

  • Academic Unit for Ageing & Stroke Research, University of Leeds, Leeds, United Kingdom.
  • School of Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, United Kingdom.
  • Institute of Population Health, University of Liverpool, Liverpool, United Kingdom.
  • Directorate of Mental Health and Learning Disabilities, Powys Teaching Health Board, Bronllys, United Kingdom.
  • School of Health and Wellbeing, General Practice and Primary Care, University of Glasgow, Glasgow, United Kingdom.
  • Leeds Institute for Data Analytics, University of Leeds, Leeds, United Kingdom.

ORCID profiles: Aseel S Abuzour, Samantha A Wilson, Alan A Woodall, Frances S Mair, Asra Aslam, Andrew Clegg, Eduard Shantsila, Mark Gabbay, Michael Abaho, Danushka Bollegala, Harriet Cant, Alan Griffiths, Layik Hama, Gary Leeming, Emma Lo, Simon Maskell, Maurice O'Connell, Olusegun Popoola, Sam Relton, Roy A Ruddle, Pieta Schofield, Matthew Sperrin, Tjeerd Van Staa, Iain Buchan, Lauren E Walker

Cite

APA

Abuzour, A. S., Wilson, S. A., Woodall, A. A., Mair, F. S., Aslam, A., Clegg, A., Shantsila, E., Gabbay, M., Abaho, M., Bollegala, D., Cant, H., Griffiths, A., Hama, L., Leeming, G., Lo, E., Maskell, S., O'Connell, M., Popoola, O., Relton, S., …, & Walker, L. E. (2026). Developing an AI-Assisted Tool That Identifies Patients With Multimorbidity and Complex Polypharmacy to Improve the Process of Medication Reviews: Qualitative Interview and Focus Group Study. Journal of Medical Internet Research, 28, e74304. https://doi.org/10.2196/74304

Vancouver

Abuzour AS, Wilson SA, Woodall AA, Mair FS, Aslam A, Clegg A, et al. Developing an AI-Assisted Tool That Identifies Patients With Multimorbidity and Complex Polypharmacy to Improve the Process of Medication Reviews: Qualitative Interview and Focus Group Study. Journal of Medical Internet Research. 2026;28:e74304. doi:10.2196/74304

BibTeX
@article{Abuzour2026,
  author = {Abuzour, Aseel S and Wilson, Samantha A and Woodall, Alan A and Mair, Frances S and Aslam, Asra and Clegg, Andrew and Shantsila, Eduard and Gabbay, Mark and Abaho, Michael and Bollegala, Danushka and Cant, Harriet and Griffiths, Alan and Hama, Layik and Leeming, Gary and Lo, Emma and Maskell, Simon and O'Connell, Maurice and Popoola, Olusegun and Relton, Sam and Ruddle, Roy A and Schofield, Pieta and Sperrin, Matthew and Van Staa, Tjeerd and Buchan, Iain and Walker, Lauren E},
  title = {Developing an AI-Assisted Tool That Identifies Patients With Multimorbidity and Complex Polypharmacy to Improve the Process of Medication Reviews: Qualitative Interview and Focus Group Study},
  journal = {Journal of Medical Internet Research},
  year = {2026},
  volume = {28},
  pages = {e74304},
  doi = {10.2196/74304}
}
Start for free →